Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

GlucoTrack, Inc. GCTK NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Instruments & Supplies • IL • USD

SharesGrow Score
63/100
2/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

GlucoTrack, Inc. (GCTK) is a Medical - Instruments & Supplies company in the Healthcare sector, currently trading at $0.73. It has a SharesGrow Score of 58/100, indicating a above average investment profile with 2 out of 7 criteria passed.

Valuation: GCTK trades at a trailing Price-to-Earnings (P/E) of -0 (S&P 500 average ~25).

Net income is $19M (loss), growing at +57.6%/yr. Net profit margin is 0% (thin). Gross margin is 0% (+0 pp trend).

Balance sheet: total debt is $33,000 against $3M equity (Debt-to-Equity (D/E) ratio 0.01, conservative). Current ratio is 1.61 (strong liquidity). Debt-to-assets is 0.4%. Total assets: $8M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 100/100 (Pass), Past 25/100 (Fail), Health 100/100 (Pass), Moat 28/100 (Fail), Future ?/100 (Fail), Income ?/100 (Fail).

GCTK SharesGrow Score Overview

63/100
SharesGrow Score
Above average fundamentals
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 100/100
Financials — average growth
PAST 25/100
strong — trend
HEALTH 100/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 28/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 0/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — GCTK

—
VALUE N/A
N/A
No analyst coverage available for this stock.
✓
GROWTH Pass
100/100
GCTK: +0%/yr revenue is, +57.6%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
✗
PAST Fail
25/100
GCTK: 1 / 4 years profitable. weak. Score = 1 / 4 × 100. ≥ 80 = Pass.
View details →
✓
HEALTH Pass
100/100
Balance sheet GCTK: Debt-to-Equity (D/E) ratio 0.01 (conservative), Current ratio is 1.61 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✗
MOAT Fail
28/100
GCTK: Gross margin is 0% (+0 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 28/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
—
INCOME N/A
N/A
No analyst coverage available for this stock.

Stock Chart & Stats

Market Data
52-Week Range0.619-15.9
Volume1.52M
Avg Volume (30D)1.41M
Market Cap$416.97K
Beta (1Y)0.35
Share Statistics
EPS (TTM)-21.56
Shares Outstanding$899.41K
IPO Date2013-04-25
Employees11
CEOPaul V. Goode
Financial Highlights & Ratios
EBITDA$-16.05M
Net Income$-19.39M
Operating Income$-16.09M
Total Cash$7.38M
Total Debt$33K
Net Debt$-7.35M
Total Assets$7.84M
Price / Earnings (P/E)-0
Analyst Forecast
Company Info
CountryIL
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS45824Q8042

Price Chart

Track all markets on TradingView
GCTK
GlucoTrack, Inc. ↗  ·  NASDAQ Capital Marke
Healthcare • Medical - Instruments & Supplies
0.62 52WK RANGE 15.90

People Also View

PDEX
PDEX
Pro-Dex, Inc.
$52.77
+0.71%
 MBOT
MBOT
Microbot Medical Inc.
$2.43
+3.40%
 STSS
STSS
Sharps Technology, Inc.
$1.74
+0.58%
 ZJYL
ZJYL
Jin Medical International Ltd.
$2.13
-7.79%
 NXGL
NXGL
NEXGEL, Inc.
$0.59
+0.85%
 LUCY
LUCY
Innovative Eyewear, Inc.
$1.09
-0.91%
 POAI
POAI
Predictive Oncology Inc.
$3.50
+2.64%
 MHUA
MHUA
Meihua International Medical Technologies Co., Ltd.
$7.61
-14.21%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message